Foto del docente

Michele Cavo

Professore Alma Mater

Alma Mater Studiorum - Università di Bologna

Professore a contratto a titolo gratuito

Dipartimento di Scienze Mediche e Chirurgiche

Pubblicazioni

Brioli A;Melchor L;Cavo M;Morgan GJ, The impact of intra-clonal heterogeneity on the treatment of multiple myeloma., «BRITISH JOURNAL OF HAEMATOLOGY», 2014, 165, pp. 441 - 454 [articolo]

Brioli A;Melchor L;Titley I;Vijayaraghavan G;Stephens C;Zeisig A;Pawlyn C;Cavo M;Morilla R;Davies FE;Morgan GJ, The impact of long-term lenalidomide exposure on the cellular composition of bone marrow., «LEUKEMIA & LYMPHOMA», 2014, 55, pp. 2665 - 2668 [articolo]

Caterina De Benedittis, Simona Soverini, Cristina Papayannidis, Michela Rondoni, Sabrina Colarossi, Francesca Dal Pero, Luca Zazzeroni, Roberta Zanotti, Giovanna De Matteis, Serena Merante, Chiara Elena, Federica Irene Grifoni, Massimiliano Bonifacio, Omar Perbellini, Giorgina Specchia, Livio Pagano, Domenica Gangemi, Patrizia Bonadonna, Lisa Pieri, Michele Cavo, Giovanni Martinelli, Ultra-Deep Sequencing (UDS) Allows More Sensitive Detection of the D816V and Other Kit Gene Mutations in Systemic Mastocytosis, «BLOOD», 2014, 124, pp. 1856 - 1856 [abstract]

De Benedittis C, Soverini S, Papayannidis C, Rondoni M, Colarossi S, Dal Pero F, Zazzeroni L, Zanotti R, De Matteis G, Merante S, Elena C, Grifoni FI, Bonifacio M, Perbellini O, Specchia G, Pagano L, Gangemi D, Bonadonna P, Pieri L, Cavo M, Martinelli G, Ultra-Deep Sequencing (UDS) allows more sensitive detection of the D816V and other kit gene mutations in systemic mastocytosis, in: ABSTRACTS, 2014, pp. 29 - 30 (atti di: ELN Frontiers Meeting 2014 – where science meets clinical practice, Berlin, Germany, 16-19 October 2014) [atti di convegno-abstract]

Papayannidis, Cristina; Ferrari, Anna; Paolini, Stefania; Baldazzi, Carmen; Sartor, Chiara; Abbenante, Mariachiara; Marconi, Giovanni; Parisi, Sarah; Volpato, Francesca; Iacobucci, Ilaria; Padella, Antonella; Guadagnuolo, Viviana; Perricone, Margherita; Robustelli, Valentina; Venturi, Claudia; Simonetti, Giorgia; Conficoni, Alberto; Mancuso, Katia; Zannetti, BEATRICE ANNA; Ottaviani, Emanuela; Zuffa, Elisa; Franchini, Eugenia; Testoni, Nicoletta; Cavo, Michele; Martinelli, Giovanni, Very Poor Outcome and Chemoresistance of Acute Myeloid Leukemia Patients with TP53 Mutations: Correlation with Complex Karyotype and Clinical Outcome, «BLOOD», 2014, 124, pp. 484 - 484 [abstract]

Stanzani M;Lewis RE;Fiacchini M;Ricci P;Tumietto F;Viale P;Ambretti S;Baccarani M;Cavo M;Vianelli N, A risk prediction score for invasive mold disease in patients with hematological malignancies, «PLOS ONE», 2013, 8, Article number: e75531, pp. 1 - 9 [articolo]Open Access

Terragna, Carolina; Remondini, Daniel; Martello, Marina; Pezzi, Annalisa; Patriarca, Francesca; Levi, Anna; Pantani, Lucia; Donnarumma, Daniela; Montanaro, Lorenzo; Crippa, Claudia; Bringhen, Sarah; Rambaldi, Alessandro; Offidani, Massimo; Corradini, Paolo; Narni, Franco; Fioritoni, Giuseppe; Zaccaria, Alfonso; Baldini, Luca; Caravita, Tommaso; La Nasa, Giorgio; Cortellazzo, Sergio; Martinelli, Giovanni; Cavo, Michele, A 41-gene signature predicts complete response (CR) to Bortezomib-Thalidomide-Dexamethasone (VTD) as induction therapy prior to autologous stem-cell transplantation (ASCT) in multiple myeloma (MM)., in: Cancer Research, 2013, pp. 2207 - 2207 (atti di: 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR), Washington, DC, USA, April 06 -10, 2013) [atti di convegno-abstract]

Clissa C;Finelli C;Follo MY; Stanzani M; Curti A; Paolini S; Papayannidis C; Mongiorgi S; Parisi S; Abbenante MC; Bosi C; Manzoli L; Martinelli G; Cocco L; Cavo M, AZACITIDINE IN HIGH AND LOW RISK MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF 57 PATIENTS TREATED WITH 4 DIFFERENT THERAPEUTIC REGIMENS, in: HAEMATOLOGICA, 2013, 98, pp. 200 - 200 (atti di: 44° Congress of the Italian Society of Hematology, VERONA, 20-23 OTTOBRE 2013) [Contributo in Atti di convegno]

Brioli A;Kaiser MF;Pawlyn C;Wu P;Gregory WM;Owen R;Ross FM;Jackson GH;Cavo M;Davies FE;Morgan GJ, Biologically defined risk groups can be used to define the impact of thalidomide maintenance therapy in newly diagnosed multiple myeloma., «LEUKEMIA & LYMPHOMA», 2013, 54, pp. 1975 - 1981 [articolo]

P. Sonneveld;H. Goldschmidt;L. Rosinol;J. Blade;J. J. Lahuerta;M. Cavo;P. Tacchetti;E. Zamagni;M. Attal;H. M. Lokhorst;A. Desai;A. Cakana;K. Liu;H. van de Velde;D.-L. Esseltine;P. Moreau, Bortezomib-Based Versus Nonbortezomib-Based Induction Treatment Before Autologous Stem-Cell Transplantation in Patients With Previously Untreated Multiple Myeloma: A Meta-Analysis of Phase III Randomized, Controlled Trials, «JOURNAL OF CLINICAL ONCOLOGY», 2013, 31, pp. 3279 - 3287 [articolo]

Abbenante, M; Papayannidis, C; Iacobucci, I; Sartor, C; Paolini, S; Ottaviani, E; Lonetti, A; Parisi, S; Ferrari, A; Guadagnuolo, V; Testoni, N; Cavo, M; Martinelli, G, CLINICAL OUTCOME OF T- ACUTE LYMPHOBLASTIC LEUKEMIA/ LYMPHOMA (T-ALL/T-LBL): THE BOLOGNA EXPERIENCE, in: supplement 1, 2013, 98, pp. 265 - 265 (atti di: 18th Congress of the European Hematology Association, Stockholm, Sweden, June 13–16, 2013) [atti di convegno-abstract]

H Avet-Loiseau;B G M Durie;M Cavo;M Attal;N Gutierrez;J Haessler;H Goldschmidt;R Hajek;J H Lee;O Sezer;B Barlogie;J Crowley;R Fonseca;N Testoni;F Ross;S V Rajkumar;P Sonneveld;J Lahuerta;P Moreau;G Morgan, Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project, «LEUKEMIA», 2013, 27, pp. 711 - 717 [articolo]

Carolina Terragna;Matteo Renzulli;Daniel Remondini;Enrico Tagliafico;Francesco Di Raimondo;Francesca Patriarca;Giovanni Martinelli;Enrica Roncaglia;Luciano Masini;Patrizia Tosi;Elena Zamagni;Paola Tacchetti;Antonio Ledda;Annamaria Brioli;Emanuele Angelucci;Nicoletta Testoni;Giulia Marzocchi;Piero Galieni;Alessandro Gozzetti;Marina Martello;Flores Dico;Katia Mancuso;Michele Cavo, Correlation between eight-gene expression profiling and response to therapy of newly diagnosed multiple myeloma patients treated with thalidomide–dexamethasone incorporated into double autologous transplantation, «ANNALS OF HEMATOLOGY», 2013, 92, pp. 1271 - 1280 [articolo]

Petrucci MT;Calabrese E;Levi A;Federico V;Ceccolini M;Rizzi R;Gozzetti A;Falco P;Lazzaro C;Martelli E;Boccadoro M;Lauria F;Liso V;Cavo M;Foa R, Cost of illness in patients with multiple myeloma in Italy: the CoMiM study, «TUMORI», 2013, 99, pp. e193 - e202 [articolo]

De Benedittis C, Soverini S, Machova Polakova K, Brouckova A, Castagnetti F, Gugliotta G, Palandri F, Papayannidis C, Klamova H, Bresciani P, Coluccio V, Salvucci M, Tiribelli M, Binotto G, Intermesoli T, Iacobucci I, Venturi C, Luppi M, Ottaviani E, MT Bochicchio, Cattina F, Mancini M, Elisa L, Haferlach T, Kohlmann A, Russo D, Rosti G, Baccarani M, Cavo M, Martinelli G., Deep sequencing of the BCR-ABL kinase domain reveals a frequency of 35INS insertion/truncation higher than expected, «HAEMATOLOGICA», 2013, 98, pp. 52 - 52 [abstract]